𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

✍ Scribed by Mohammad H. Pourgholami; Michael Szwajcer; Melvin Chin; Winston Liauw; Jonathan Seef; Peter Galettis; David L. Morris; Matthew Links


Publisher
Springer
Year
2009
Tongue
English
Weight
341 KB
Volume
65
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II trial of weekly high dose con
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer